These outcomes not only improve patient health and quality of life but also increase physician confidence in prescribing GLP-1 therapies
Source Data are provided in Source Data
If it still hurts, speak with a doctor
Post hoc, the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT) trial, which was the first to assess GLP-1 receptor agonists in participants without diabetes, was incorporated into the analysis
Due to the fact that amlodipine exhibits anti-glycation activity, its effect in diseases associated with hyperglycemia and increased oxidative stress should be investigated in both type 1 and type 2 diabetes, diabetic nephropathy, diabetic retinopathy, atherosclerosis, and hypertension 59
Role in Satiety: Both contribute to the regulation of appetite and promote satiety